Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,371
Recruiting: 3,969
Ph III recruiting: 536
Growth YoY: +9.5%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,407)

clinicaltrialsPublishedShowing 951–1,000 of 8,907 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07218315	Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma	recruiting	N/A	15	M.D. Anderson Cancer CenterOTHER	1	Sep 11, 2026	clinicaltrials
NCT07238023	Promoting Active Living Among People With Advanced Cancer	active not recruiting	N/A	36	University of OklahomaOTHER	1	Sep 11, 2026	clinicaltrials